Webinars

Legal landscapes in precision medicine Episode 2: Market access and intellectual property law

Understanding complex disease biology: Insights into the genetics of long COVID 

From genome to bedside: How genetics is transforming modern medical practice

Unlocking potential: How AI is shaping the drug development pipeline

Sano product spotlight

Parkinson's disease: Engagement, screening, and retention

Genetic essentials for clinical research professionals: Part 2

New beginnings: Clinical, social, and ethical perspectives on newborn genome sequencing

Legal landscapes in precision medicine Episode 1: Patient privacy and the intricacies of clinical trials

Empowering ALS families: Insights and support strategies

Dr. Patrick Short is joined by Paul Wicks and Daniel Barvin for a webinar focusing on the essential role families play in supporting those affected by ALS (Amyotrophic Lateral Sclerosis), including individuals who are gene carriers of the condition.

Inside MASH: Exploring detection, treatment, and future directions

Join host Dr. Patrick Short for an insightful webinar with Dr. Dimitar Tonev. This session provides valuable details into the evolving landscape of metabolic dysfunction-associated steatohepatitis  (MASH), including diagnosis, treatment breakthroughs, and future directions.

Genetics essentials for clinical research professionals

Join host Dr. Patrick Short as he discusses the essentials of genetics and genomics, including genetic variation, genetic testing, and more.

International perspectives on genetic testing in ALS

Join host Dr. Paul Wicks in discussion with Ammar Al-Chalabi, PhD, Kristiana Salmon, and Dr. Patrick Short about global genetic testing for ALS.

Representation matters: Why equitable access and community engagement are critical in genetic research

Join host Lindsey Wahlstrom-Edwards, MPH in discussion with Natasha Ratcliffe, Ebony Scott, and Del Smith, PhD, on the techniques used by industry-leading patient advocacy groups to make research more diverse and representative. 

Does the age of onset in SOD1-mediated ALS affect the speed of progression?

Join host Dr. Paul Wicks and Dr. Sarah Opie-Martin as they discuss the latest research on SOD1 gene variants and their association with ALS. 

The technical challenges of biomarker-based pre-screening

Join host Dr. Patrick Short in an informative conversation with William Jones, about the technical complexities of managing comprehensive pre-screening programs that encompass biomarkers, patient-reported outcomes, and medical records. 

Overcoming the challenges of decentralised clinical trials

Join host Dr. Paul Wicks in conversation with Craig Lipset and Liam Eves focussed on some of the major challenges of decentralised and hybrid clinical trials, solutions to overcome them, and some practical examples.

Patient engagement in precision medicine research

Join host Dr. Paul Wicks in a discussion with Jillian Hastings Ward, Rebecca Middleton, and John Wilbanks. The discussion focussed how patients can be more involved in precision medicine research, as well as how design systems can impact engagement.

Connecting for success: The power of purposeful participant engagement

Join Sano team members Ross Rounsevell and George Bowley as they explore how new technology can help simplify patient engagement processes.

Genetic testing 201: Considerations and next steps for sharing your results

Join host Dr. Patrick Short and guests Krista Qualmann and Jessi Keavney in conversation about how and when to share genetic testing results. 

The genetics of MASLD and MASH

Join host Lindsey Wahlstrom-Edwards, MPH, with guests Wayne Eskridge and Neeraj Mistry in a discussion about the genetics of liver disease and how Sano and the Fatty Liver Foundation are working together to accelerate precision medicine in this area. 

An insider’s view on
drug development in MASH
with Dimitar Tonev

Join host Dr. Patrick Short in conversation with Dr. Dimitar Tonev about the MASH therapy landscape, the importance of genetics in trial recruitment, and the controversial topics that should be addressed to bring real improvements to MASH patients.

Opportunities in improving recruitment in decentralized clinical trials

Join host Dr. Patrick Short in conversation with Joss Warren on developing collaborative solutions with industry leading technologies and services that integrate with decentralised clinical trial platforms.

How patient organizations can support innovation and keep their community's health information safe

Join host Dr. Patrick Short in conversation with Lindsey Wahlstrom-Edwards about the impact of genetics on personalised medicine and the vital importance of data security and patient ownership.

Non-invasive screening and genomics in MASLD with the Fatty Liver Foundation

Join host Dr. Patrick Short with guests Wayne Eskridge and Neeraj Mistry in a discussion about early detection in metabolic dysfunction-associated steatotic liver disease (MASLD) and MASH using genetics, non-invasive liver testing, and other new technologies.

Meaningful technology, Genomics England

Join host Dr. Paul Wicks in a conversation with Jillian Hastings Ward, Rahki Rajani, and Dr. Patrick Short. The discussion focussed on what taking a participant-centric approach can mean for organisations supporting research.

Participant diversity: Increasing the impact of biomedical research

Join host Dr. Patrick Short with guests Mavis Machirori, Charles Steward, and Jessica Mai Sims as they discuss the topic of participant diversity in biomedical research. 

Beyond the genome: Ethical and regulatory landscapes in precision medicine

Join Sarah Howard, Sano's Head of Quality and Regulatory, as she discusses the regulatory landscape, ethical considerations, and data management and privacy in precision medicine trials. 

Precision medicine research in Multiple Sclerosis: What is on the horizon?

Join host Dr. Patrick Short in a conversation with Dr. Mark Kotter about the future of precision medicine treatments for Multiple Sclerosis.

How can applying a ‘rare disease mindset’ accelerate and de-risk precision medicine trials?

Join host Dr. Patrick Short and Patti Engel as they discuss lessons from a success story in running a proactive patient finding programme that combined HCP outreach, direct-to-patient outreach, free next-generation DNA sequencing, and a decentralised trial design.